- Home
- DRUG vs BOOM Comparison
DRUG vs BOOM Comparison
Compare DRUG & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- BOOM
- Stock Information
- Founded
- DRUG 2019
- BOOM 1965
- Country
- DRUG United States
- BOOM United States
- Employees
- DRUG N/A
- BOOM N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- BOOM Industrial Specialties
- Sector
- DRUG Health Care
- BOOM Industrials
- Exchange
- DRUG Nasdaq
- BOOM Nasdaq
- Market Cap
- DRUG 199.7M
- BOOM 166.0M
- IPO Year
- DRUG N/A
- BOOM N/A
- Fundamental
- Price
- DRUG $25.41
- BOOM $8.59
- Analyst Decision
- DRUG Strong Buy
- BOOM Buy
- Analyst Count
- DRUG 7
- BOOM 2
- Target Price
- DRUG $83.25
- BOOM $16.25
- AVG Volume (30 Days)
- DRUG 60.0K
- BOOM 163.7K
- Earning Date
- DRUG 08-13-2025
- BOOM 07-31-2025
- Dividend Yield
- DRUG N/A
- BOOM N/A
- EPS Growth
- DRUG N/A
- BOOM N/A
- EPS
- DRUG N/A
- BOOM N/A
- Revenue
- DRUG N/A
- BOOM $635,272,000.00
- Revenue This Year
- DRUG N/A
- BOOM N/A
- Revenue Next Year
- DRUG N/A
- BOOM $4.32
- P/E Ratio
- DRUG N/A
- BOOM N/A
- Revenue Growth
- DRUG N/A
- BOOM N/A
- 52 Week Low
- DRUG $0.93
- BOOM $6.02
- 52 Week High
- DRUG $79.02
- BOOM $15.14
- Technical
- Relative Strength Index (RSI)
- DRUG 43.34
- BOOM 60.46
- Support Level
- DRUG $26.09
- BOOM $8.31
- Resistance Level
- DRUG $27.50
- BOOM $8.83
- Average True Range (ATR)
- DRUG 1.95
- BOOM 0.47
- MACD
- DRUG 0.12
- BOOM 0.02
- Stochastic Oscillator
- DRUG 44.62
- BOOM 75.60
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About BOOM DMC Global Inc.
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.